Sign in

Daniela Thommen

@danielathommen.bsky.social
1.2K followers 180 following 4 posts

Precision cancer immunotherapy, T cell immunology, patient-derived tumor immune models | Group leader at NKI and Oncode Institute Amsterdam

PostsRepliesMedia
Reposted by Daniela Thommen
EU-LIFE @eu-life.bsky.social · 23/09/2026
💡 Welcome to #EULIFEspotlight! This month we celebrate Hongchang Fu, Postdoc Project Research Scientist in Samra Turajlić Group at @crick.ac.uk In this blog post, he shared his experience at EU-LIFE Connects Science 2026, hosted by Daniela Thommen at @nkinl.bsky.social eu-life.eu/newsroom/new...
"I have always believed that science advances not only through experiments and publications, but also through conversations among people, teams and institutes. These exchanges allow us to view our own research from another perspective, learn different ways of working, and build trust that sustains long-term collaboration," said Hongchang Fu.
011
Daniela Thommen @danielathommen.bsky.social · 28/09/2025
Are exhausted T cells functionless? Absolutely not! We found that dysfunctional T cells are key initiators of early tissue responses to PD-1 blockade and equipped to rapidly regain anti-tumor function via restoration of translational control. See new preprint from the lab led by Paulien Kaptein
biorxiv.org
Reinvigoration of translational activity in dysfunctional T cells initiates the early intratumoral response to PD-1 blockade
T cells are key effectors of antitumor responses elicited by PD-1 blockade. However, it remains elusive by which mechanism(s) PD-1 blockade initiates T cell-driven antitumor immunity in cancer tissues...
082
Reposted by Daniela Thommen
Netherlands Cancer Institute @nkinl.bsky.social · 26/03/2025
Congratulations @jacqjacobs.bsky.social @riklindeboom.bsky.social @danielathommen.bsky.social on receiving a ZonMw open competition
031
Daniela Thommen @danielathommen.bsky.social · 19/03/2025
Very proud of our postdoc @christinamt.bsky.social @nkinl.bsky.social who was awarded an EACR-Mark Foundation Postdoctoral Fellowship! Congratulations to the other awardees and thanks to @helloeacr.bsky.social and @themarkfdn.bsky.social for this fantastic support!
250
Reposted by Daniela Thommen
Johanna Joyce @johannajoyce.bsky.social · 19/03/2025
Well done to the first recipients of the EACR-Mark Foundation postdoc fellowships 🎉🎊 And a happy coincidence that all three awardees are women scientists in the labs of three women PIs 🙌 #WomeninSTEM #WomeninScience 👩‍🔬👩🏻‍🔬🧪 @themarkfdn.bsky.social @helloeacr.bsky.social @juliemmazet.bsky.social
0448
Reposted by Daniela Thommen
ACIR @acir-org.bsky.social · 05/03/2025
For those who couldn't attend the new #AACRIO25 meeting, check out our digest here 👉 bit.ly/3XvBUkp. We included talks from @jimallisonphd.bsky.social, @danielathommen.bsky.social, @jcstark.bsky.social and more! (1/2)
133
Reposted by Daniela Thommen
Jon Lim, FRCP PhD @drjonlim.bsky.social · 12/12/2024
📚 In conjunction with #ESMOImmuno24, we had our annual #ESMO #IOTECH Editorial Board meeting today - delighted to see many more academics now here 🦋. 🎯 EiC: @haanenjohn.bsky.social Section Editors: @michalbassani.bsky.social (NeoAg/TILs) @danielathommen.bsky.social (Biomarkers/novel IO targets)...
153
Reposted by Daniela Thommen
Zayd Tippu @zaydtippu.bsky.social · 11/12/2024
🎬 Fantastic start to #ESMOImmuno24 with ESMO-SITC primer. Highlighting challenges of IO biomarker discovery: 🔴 Heterogeneity in data, samples and assay types 🧬 Need for cross-study harmonisation & tailored composite biomarkers 💊 Neoadj. trials & PDTF’s offer opportunities for biomarker discovery!
063
Reposted by Daniela Thommen
Jacqueline Jacobs @jacqjacobs.bsky.social · 29/11/2024
Future PhD students, check out our NKI PhD program: bsky.app/profile/nkin...
012